Dr. Lucia Nappi has been appointed Senior Research Scientist at our Centre. Dr. Nappi (MD, PhD) is a medical oncologist with a strong clinical and translational background.
Congratulations to Dr. Wilf Jefferies on being the first Canadian immunologist to be elected as a Fellow of the National Academy of Inventors. Election as a Fellow of the NAI is the highest professional distinction accorded solely to eminent academic inventors.
The Michael Smith Laboratories news post is below; click here to read it at the MSL's website (opens in new window).
Dr. Nada Lallous has been appointed Senior Research Scientist at our Centre. She discusses the role of our Centre's new protein bioengineering core (enabled in part by CFI and BC-KDF funding) in the latest VCH News.
Congratulations to Dr. Amina Zoubeidi on her promotion to Professor, Department of Urologic Sciences, University of British Columbia (UBC).
This promotion relfects Dr. Zoubeidi's contributions in teaching, graduate supervision, research and service within the UBC community, and her outstanding research career to date.
September 16, 2019 - Prostate Cancer Canada today announced a $2 million investment in prostate cancer research, awarding 10 projects Prostate Cancer Canada and Movember 2019 Discovery Grants. Grant recipients include the Vancouver Prostate Centre's Drs Cox, Gleave and Goldenberg.
Each year, the UBC Faculty of Medicine recognizes faculty and staff members for excellence in teaching, research, administration, innovation and public service. This year, UBC Faculty of Medicine Distinguished Achievement Awards were given to Dr. Alexander Wyatt (Excellence in Basic Science Research) and Dr. Poul Sorensen (Overall Excellence – Senior Faculty).
The Vancouver Prostate Centre has recently acquired and commissioned a state-of-the-art high resolution (29 MHz) micro-ultrasound machine —called the ExactVu micro-ultrasound -- for use in image-guided targeted biopsies of the prostate. This technology, which is now part of our regular clinical workflow, enables our urologists to accurately identify and biopsy cancer lesions in the prostate, and can also be used as an aid in delivering targeted focal therapies to the tumour.
Dr. Ryan Flannigan and his colleagues are studying a new treatment for men suffering from chronic scrotal pain.